Larimar Therapeutics, Inc. (LRMR)

Last Closing Price: 3.23 (2026-11-18)

Operating Income (Quarterly)

Operating Income: The income after operating expenses.

Larimar Therapeutics, Inc. (LRMR) had Operating Income of $-32.46M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-29.71M
--
--
$32.46M
Operating Income
$-32.46M
$1.33M
$-31.14M
$-31.14M
$-31.14M
$-31.14M
$-31.14M
$-31.14M
$-32.46M
$-32.97M
104.21M
104.21M
$-0.29
$-0.29
Balance Sheet Financials
$136.15M
$0.60M
$4.35M
$140.50M
$35.65M
--
$3.39M
$39.04M
$101.47M
$101.47M
$101.47M
104.63M
Cash Flow Statement Financials
$-119.83M
$0.52M
$110.73M
$86.02M
$77.44M
$-8.58M
$6.30M
--
--
Fundamental Metrics & Ratios
3.82
--
--
--
--
--
--
--
--
--
--
$-119.99M
--
--
--
--
--
--
--
-30.69%
-30.69%
-22.16%
-30.69%
$0.97
$-1.15
$-1.15